Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Star Combo PharmaASX:S66 35 PB Ratio is 0.46 as of Aug. 02, 2026, which is 41% below its 10-year median of 0.78. GuruFocus rates ASX:S66 with a GF Score™ of 35/100 and a GF Value™ of A$0.13 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,898 Consumer Packaged Goods companies, Star Combo Pharma ranks better than 89.46% on this metric.
Star Combo Pharma Ltd stock PB Ratio (=0.42) is close to 2-year low of 0.39.
The historical rank and industry rank for Star Combo Pharma's PB Ratio or its related term are showing as below:
ASX:S66'
s PB Ratio Range Over the Past 10 Years
Min: 0.37 Med: 0.78 Max: 4.56
Current: 0.46
During the past 9 years, Star Combo Pharma's highest PB Ratio was 4.56. The lowest was 0.37. And the median was 0.78.
ASX:S66's PB Ratio is ranked better than 89.46% of 1898
companies
in the Consumer Packaged Goods industry
Industry Median: 1.36
vs ASX:S66: 0.46
During the past 12 months, Star Combo Pharma's average Book Value Per Share Growth Rate was 14.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 2.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -3.10% per year.
During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Star Combo Pharma was 16.40% per year. The lowest was -9.30% per year. And the median was 3.40% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Star Combo Pharma PB Ratio Related Terms
Star Combo Pharma PB Ratio Historical Data
* Premium members only.
The historical data trend for Star Combo Pharma's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Star Combo Pharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Star Combo Pharma PB Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Star Combo Pharma's PB Ratio distribution charts can be found below:
* The bar in red indicates where Star Combo Pharma's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Star Combo Pharma (ASX:S66) has a PB Ratio of 0.46 as of Aug. 02, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Star Combo Pharma and its competitors. This is 41% below median its historical median of 0.78. Over the past decade, Star Combo Pharma's PB Ratio has ranged from 0.37 to 4.56. According to the industry distribution chart, Star Combo Pharma ranks #200 out of 1898 companies in the Consumer Packaged Goods industry, placing it in the top 10.5%.
Is Star Combo Pharma's PB Ratio too high?
Star Combo Pharma's current PB Ratio of 0.46 is 41% below median its 10-year median of 0.78. Over the past 10 years, this metric has ranged from a low of 0.37 to a high of 4.56. The Consumer Packaged Goods industry median PB Ratio is 1.36. Star Combo Pharma's value of 0.46 is 66.2% below this industry median. Based on the distribution chart, Star Combo Pharma ranks #200 out of 1898 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Star Combo Pharma has a GF Score™ of 35/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Star Combo Pharma's PB Ratio compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Star Combo Pharma ranks #200 out of 1898 companies for PB Ratio. This places Star Combo Pharma in the top 11% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.36. Star Combo Pharma's value of 0.46 is 66.2% below this benchmark. Historically, Star Combo Pharma's own PB Ratio has ranged from 0.37 to 4.56 over the past decade. While the company's 10-year median is 0.78 vs. the industry median of 1.36, Star Combo Pharma has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Consumer Packaged Goods company?
The median PB Ratio among Consumer Packaged Goods companies is 1.36, based on 1,898 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Star Combo Pharma's current PB Ratio of 0.46 is 66.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Star Combo Pharma and its competitors. For the Consumer Packaged Goods industry, the median PB Ratio is 1.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Star Combo Pharma's current PB Ratio is 0.46, which is 41% below median its own 10-year median of 0.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Combo Pharma stock overvalued right now?
Based on GuruFocus' analysis, Star Combo Pharma (ASX:S66) is currently considered Fairly Valued. The stock's GF Value™ is A$0.13, compared to a current price of A$0.13 — trading right at its estimated fair value. The current PB Ratio is 0.46, which is 41% below median its 10-year median of 0.78 and 66.2% below the Consumer Packaged Goods industry median of 1.36. Star Combo Pharma's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Star Combo Pharma (ASX:S66), the current PB Ratio is 0.46 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Star Combo Pharma (ASX:S66) Overvalued in 2026?
Based on GuruFocus' analysis, Star Combo Pharma stock appears to be undervalued.
The current stock price of A$0.13 is trading 0% below its estimated GF Value™ of A$0.13.
GuruFocus considers Star Combo Pharma to be Fairly Valued.
Key valuation signals for ASX:S66:
PB Ratio: 0.46 (41% below median its 10-year median of 0.78)
GF Value™: A$0.13 vs. price of A$0.13 (0% below fair value)
Industry Position: 66.2% below the Consumer Packaged Goods median (#200 of 1898)
No single metric tells the full story. See the ASX:S66 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Star Combo Pharma Ltd is engaged in the manufacturing and distribution of food products and nutritional supplements. The company offers products such as Costar, Living Healthy, Amax, and J&K. It operates in two segments. The Star Combo segment engages in the development, manufacturing, marketing, and sales of natural health supplements and skincare products. The Austoyou retail business segment consists of the Australia-China e-commerce platform that offers product lines directly to Chinese health product consumers, and Koala Mall's two retail stores in Sydney. Geographically, it operates in China and Australia.
35GF Score
Get the complete analysis for ASX:S66
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:S66 has been successfully added to your 
